Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53783

language	eng
Author	Sugano Kentaro Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan the Esomeprazole NSAID Preventive Study Group, Japan Kinoshita, Yoshikazu Miwa Hiroto Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan Takeuchi Tsutomu Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
Subject	Esomeprazole; Non-steroidal anti-inflammatory drugs; Peptic ulcer; Safety
Journal Title	BMC GASTROENTEROLOGY
Volume	13
ISSN（Online）	1471-230X
Published Date	2013-03-26
DOI	10.1186/1471-230X-13-54
PubMed ID	23530709
Publisher	BMC
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	Kentaro Sugano: Advisory Board member (AstraZeneca K.K. and Takeda Pharmaceutical Co. Ltd), service honoraria (Takeda Pharmaceutical Co. Ltd) and research grants (Astellas Pharma Inc., AstraZeneca K.K., Eisai Co. Ltd, Otsuka Pharmaceutical Co. Ltd, Chugai Pharmaceutical Co. Ltd, MSD K.K. and Takeda Pharmaceutical Co. Ltd).; Yoshikazu Kinoshita: service honoraria (Astellas Pharma Inc., AstraZeneca K.K., Eisai Co. Ltd and Takeda Pharmaceutical Co. Ltd) and research grants (Astellas Pharma Inc., AstraZeneca K.K. and Eisai Co. Ltd).; Hiroto Miwa: service honoraria (Astellas Pharma Inc., AstraZeneca K.K., Eisai Co. Ltd, Dainippon Sumitomo Pharma Co. Ltd and Takeda Pharmaceutical Co. Ltd) and research grants (Astellas Pharma Inc., AstraZeneca K.K., Dainippon Sumitomo Pharma Co. Ltd and Eisai Co. Ltd and Otsuka Pharmaceutical Co. Ltd).; Tsutomu Takeuchi: service honoraria (Abbott Japan Co. Ltd, Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd, Eisai Co. Ltd, Mitsubishi Tanabe Pharma Co. and Pfizer Japan Inc.) and research grants (Abbott Japan Co. Ltd, Astellas Pharma Inc., Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd, Daiichi Sankyo Co. Ltd, Eisai Co. Ltd, Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Nippon Shinyaku Co. Ltd, Novo Nordisk Pharma Ltd, Otsuka Pharmaceutical Co. Ltd, Pfizer Japan Inc., Sanofi K.K., Santen Pharmaceutical Co. Ltd, Takeda Pharmaceutical Co. Ltd and Teijin Pharma Ltd).; This study was funded by AstraZeneca K.K. (Japan), the manufacturer of esomeprazole. Medical writing services from Anna Mett and Steve Winter of inScience Communications, Springer Healthcare were funded by AstraZeneca K.K. (Japan).